Boundary Capital announces latest investments

/
Date02 Jun 2016
/
Categories

Boundary Capital has announced its latest investments in Toxibact, a disruptive technology which has the potential to kill a wide range of microorganisms and AB-Polyblok, a revolutionary technology which has the potential to treat, and potentially partially reverse, the effects of Alzheimer’s Disease.